N-(4-methoxyphenyl)-4-benzoyloxy-1,2-dihydro-5-methoxy-1-methyl-2-oxoquinoline-3-carboxamide | 1373261-44-9

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 缩酚酸和缩酚酸环醚类
• 英文名称: N-(4-methoxyphenyl)-4-benzoyloxy-1,2-dihydro-5-methoxy-1-methyl-2-oxoquinoline-3-carboxamide
• 英文别名: [5-Methoxy-3-[(4-methoxyphenyl)carbamoyl]-1-methyl-2-oxoquinolin-4-yl] benzoate
• CAS: 1373261-44-9
• 化学式: C₂₆H₂₂N₂O₆
• 分子量: 458.47
• InChiKey: VOLIULFAMNFZBA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  34
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  94.2
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• 1,2-DIHYDRO-4-HYDROXY-2-OXO-QUINOLINE-3-CARBOXANILIDES AS AHR ACTIVATORS
  申请人：Pettersson Lars

  公开号：US20130203703A1

  公开（公告）日：2013-08-08

  The present invention relates to compounds which are 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides, their thieno-pyridone analogs, and prodrugs thereof. This invention specifically relates to such derivatives containing an N-hydrogen in the carboxanilide moiety and which exhibit modulating activity towards the aromatic hydrocarbon receptor (AhR), and, specifically, also to prodrugs thereof. The present invention also relates to use of said compounds as a medicament, and for the treatment of cancer, autoimmune disorders and other disorders with an immunological component, and a pharmaceutical composition comprising one or more of said compounds and a method of treatment.

  本发明涉及1,2-二氢-4-羟基-2-氧代-喹啉-3-羧酰苯胺类化合物、其噻吩-吡啶酮类似物以及它们的前药。本发明具体涉及含有羧酰苯胺基团中的N-氢的衍生物，它们表现出对芳香族碳氢受体（AhR）的调节活性，以及它们的前药。本发明还涉及所述化合物作为药物的用途，用于治疗癌症、自身免疫性疾病以及其他具有免疫学成分的疾病，以及一种包含一种或多种所述化合物的药物组合物和一种治疗方法。
• US8962598B2
  申请人：——

  公开号：US8962598B2

  公开（公告）日：2015-02-24